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ABSTRACT
Background: Substantial grey matter (GM) demyelina-
tion occurs in both the cerebral cortex and spinal cord in
multiple sclerosis (MS). GM demyelination also occurs in
the cerebellar cortex and the deep GM nuclei of the brain.
However, no study has made a direct ‘‘within subject’’
comparison of the extent of GM pathology between these
regions.
Aim: To examine the extent and pattern of GM
demyelination in the motor cortex, cingulate gyrus,
cerebellum, thalamus and spinal cord in MS.
Methods: Postmortem study using material from 14 MS
cases and three controls. Sections were taken from the
five predetermined areas and stained for proteolipid
protein. The extent of GM and white matter (WM)
demyelination was assessed in each region.
Results and conclusion: Overall, 28.8% of the GM was
demyelinated compared with 15.6% of the WM
(p,0.001), with demyelination being greater in the GM
than in the WM at each of the anatomical sites. There
was substantial variation in the extent of demyelination
between the different CNS regions. GM demyelination
was most extensive in the spinal cord and cerebellum
while WM demyelination was most prominent in the
spinal cord.
The factors influencing plaque topography in
multiple sclerosis (MS) are not fully understood.
The majority of white matter (WM) plaques occur
in a perivenular distribution, with areas containing
a high density of small veins and venules—such as
the periventricular WM, leucocortical junction and
the WM tracts of the brainstem and spinal cord—
showing a preponderance for demyelination.1
While it has been recognised that MS also involves
grey matter (GM) structures, the conventional
myelin stains used in these studies grossly under-
estimate the true extent of this GM pathology.2–4
In comparison, myelin protein immunohisto-
chemistry is more sensitive for detecting GM
demyelination, demonstrating extensive demyeli-
nation in the cerebral cortex and spinal cord GM in
MS.4–6 However, it is unclear whether GM demye-
lination is more prominent in the spinal cord, the
cerebral cortex or other GM structures; compar-
isons between studies are likely to be confounded
by differences in MS subtype, disease duration, age,
gender, etc. Therefore, in this study, we used
autopsy material to quantify GM and WM
demyelination in the cerebral cortex, cerebellum,
spinal cord and thalamus, allowing us to make
‘‘within subject’’ comparisons of the extent of
demyelination in these regions.
MATERIALS AND METHODS
Clinical material
Formalin fixed, paraffin embedded autopsy
material was obtained from 14 pathologically
confirmed MS cases and three controls (MS Brain
Bank, London, UK). Patients with MS (one man,
13 women) were aged 44–81 years (mean 56.6,
median 56) with disease durations of 6–32 years
(mean 23.7, median 22). Eleven cases had second-
ary progressive MS (SPMS), two primary progres-
sive MS (PPMS) and one relapsing remitting MS
(RRMS). The controls (two women aged 69 and
78 years, one man aged 35 years) had no clinical or
pathological evidence of neurological disease. The
local research ethics committee approved the
study.
Preparation of the sections
Sections (5 mm) were taken from seven predeter-
mined areas of the CNS, irrespective of the
macroscopic appearance: the motor cortex, cingu-
late gyrus, cerebellum, thalamus and spinal cord
(transverse sections from the cervical, thoracic and
lumbar levels). Sections were stained for proteo-
lipid protein (PLP) as described previously.6
Measurement of GM and WM lesions
The PLP stained sections were scanned in a slide
scanner to produce a digital image. Using these
images the GM/WM boundary and the MS lesions
were manually outlined (AnalySIS Pro running SIS
software; Olympus UK). The control cases were
used to establish normal regional variations in
myelin staining. Lesions were defined as sharply
demarcated areas, characterised by either complete
myelin loss or markedly reduced myelin density
(likely to represent partially remyelinated lesions).
The proportion of GM that was demyelinated
(PGMd, ie, the area of demyelinated GM as a
percentage of the total GM cross sectional area)
and the proportion of WM that was demyelinated
(PWMd) was then calculated.
Statistical analysis
Paired t tests were used to compare PGMd with
PWMd in each anatomical region (ie, each tissue
section contained both GM and WM, hence paired
tests). Correlations between PGMd and PWMd were
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Table 1 Frequency of lesions in the five anatomical regions
Location
Tissue sections
examined
Areas of GM demyelination Areas of WM demyelination
No
Proportion that are
pure GM lesions (%)* No
Proportion that are
pure WM lesions (%)
Cingulate 13 20 90 9 77.8
Motor cortex 12 28 100 2 100
Deep GM 13 36 87.5 13 61.5
Cerebellum 13 79 50.6 41 56.1
Spinal cord 37 42 16.7 70 14.3
Spinal cord values represent the pooled results from the three cord levels.
*Pure GM lesions (ie, lesions that are restricted to the GM and do not impinge on the adjacent WM).
GM, grey matter; WM, white matter.
Figure 1 PLP immunostaining of the
cerebral cortex in controls (A, C) and in
patients with multiple sclerosis (B, D–F).
(A, C) In controls, PLP staining is reduced
in GM in comparison with WM,
particularly in the superficial cortex (C).
(B) Subpial lesion extending over the
cingulate gyrus (arrows = lesion border).
(D) Subpial lesion at high magnification. In
comparison, leucocortical (E) and
intracortical (F) lesions are smaller and
often perivenular in distribution. Broken
lines = GM/WM boundary. GM, grey
matter; PLP, proteolipid protein; WM,
white matter. Scale bars 500 mm.
Research paper
J Neurol Neurosurg Psychiatry 2009;80:182–187. doi:10.1136/jnnp.2008.148767 183
 group.bmj.com on August 16, 2011 - Published by jnnp.bmj.comDownloaded from 
assessed using Spearman’s ranked test. Multiple regression
analyses were used to examine the influence of age, anatomical
location and disease duration on PGMd and PWMd (Stata V.9;
StataCorp, Texas, USA).
RESULTS
Lesion counts and morphology
The frequency of GM and WM plaques in each CNS region is
shown in table 1. Within the cerebral cortex, thalamus and
cerebellum, the majority of GM plaques were restricted to the
GM and did not impinge on the WM (95.8%, 87.5% and 50.6%,
respectively). In contrast, only 16.7% of spinal cord GM plaques
involved the GM exclusively. The majority of lesions in the
cerebral cortex were subpial in location (72% by number, 96%
by area). Plaque morphology is illustrated in fig 1 (cerebral
cortex), fig 2 (cerebellar cortex) and fig 3 (thalamus and spinal
cord). We observed evidence of ongoing demyelination (ie,
macrophages containing PLP inclusions) in only one case (one
subcortical WM lesion and four thalamic lesions—three GM
lesions, one mixed GM/WM lesion).
Demyelination is more extensive in the GM than the WM
Overall, PGMd (mean 28.8%) was significantly greater than
PWMd (15.6%) (p,0.001). PGMd correlated with PWMd
(r = 0.7621, p,0.001).
PGMd was greater than PWMd in the motor cortex (p = 0.0128),
cerebellum (p = 0.0055) and spinal cord (cervical, p = 0.0464;
thoracic, p = 0.0082; lumbar, p = 0.0693) (fig 4). The difference
was not significant in the cingulate (p = 0.1185) or thalamus
(p = 0.3885).
Regional differences in the extent of demyelination
To examine for regional differences in the extent of GM
demyelination, PGMd was regressed on anatomical location
controlling for age and disease duration. In comparison with the
cervical cord, PGMd was significantly reduced in the motor
cortex (coefficient of regression (coeff) =20.4703, p,0.001—ie,
PGMd was, on average, 47% greater in the cervical cord than in
the motor cortex), the cingulate (coeff =20.3220, p = 0.001)
and the thalamus (coeff =20.4449, p,0.001). PGMd was not
significantly different in the cerebellum (coeff =20.0217,
p = 0.875), thoracic cord (coeff = 0.0984, p = 0.416) or lumbar
cord (coeff =20.0829, p = 0.538) in comparison with the
cervical cord. PGMd was greater in the cingulate than in the
motor cortex (p = 0.013).
In comparison with the lumbar cord, PWMd was reduced in
the WM adjacent to the motor cortex (coeff =20.2975,
p = 0.003), cingulate (coeff =20.2499, p = 0.014), thalamus
(coeff =20.2548, p = 0.021) and cerebellum (coeff =20.1982,
p = 0.053) but not the cervical (coeff =20.0829, p = 0.538) or
thoracic cord (coeff = 0.0984, p = 0.416).
Figure 2 PLP immunostaining of the cerebellum. (A–D) Control; in comparison with the WM, there is a paucity of myelin within the Gr and Pu layers,
while the outermost Mo layer is devoid of myelin. (C, D) Pu (C) and Gr (D) layers at higher magnification. (E–I) Multiple sclerosis case. (E, F) Mixed GM/
WM lesions. (G, H) A proportion of cerebellar plaques are characterised by complete myelin loss in the cortex, with sparing of the subcortical WM. (I)
Demyelination in the Gr layer is invariably accompanied by demyelination in the Pu layer and vice versa. GM, grey matter; Gr, granular cell; Mo,
molecular; PLP, proteolipid protein; Pu, Purkinje; WM, white matter.
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The correlation between PGMd and PWMd varied between
sites, being greatest in the spinal cord (eg, thoracic cord;
r = 0.908, p,0.001) and thalamus (r = 0.569, p = 0.042). The
two variables did not correlate in the cerebral cortex (eg,
cingulate; r = 0.161, p = 0.6) and cerebellum (r = 0.534,
p = 0.060). PGMd in the cingulate correlated with PGMd in the
cerebellar cortex (r = 0.745, p = 0.003), but not in the spinal
cord (eg, thoracic cord; r = 0.407, p = 0.214).
Influence of age, sex and disease duration on extent of
demyelination
Age (coefficient of regression (coeff) =20.0134, p = 0.004)
appeared to have a significant influence on PGMd, with younger
patients having greater GM demyelination. Disease duration did
not appear to influence PGMd (coeff = 0.0091, p = 0.179).
Both age (coeff =20.0100, p = 0.003) and disease duration
(coeff = 0.0092, p = 0.049) appeared to have a significant
influence on PWMd with more extensive demyelination being
observed in younger patients and those with longer disease
durations.
DISCUSSION
Numerous studies have examined the distribution of MS
plaques within the CNS using histochemical myelin stains.2 3
This work has suggested that while demyelination occurs in
both WM and GM structures, MS is predominantly a WM
disease. However, such studies are likely to have substantially
underestimated the extent of GM involvement.4 6 7 In light of
this, it is essential that the extent and pattern of demyelination
in MS is re-evaluated using more sensitive methods of lesion
Figure 3 PLP immunostaining of the
thalamus (A–D) and spinal cord (E–G). (A)
Control showing GM nuclei interspersed
with WM. (B–G) Multiple sclerosis cases.
(B) Multiple demyelinated plaques, largely
within the GM. (C, D) Subependymal
periventricular GM plaque. (E) Two mixed
GM/WM plaques in the cervical cord,
both displaying a complete disregard for
the GM/WM boundary. Note the paucity
of myelin staining within the SG of the
GM, also observed in controls. (F, G) A
proportion of spinal plaques maintain a
strict respect for the GM/WM boundary.
Broken lines = GM/WM boundary. GM,
grey matter; PLP, proteolipid protein; SG,
substantia gelatinosa; WM, white matter.
Scale bars 500 mm.
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detection. Therefore, we have used myelin protein immunohis-
tochemistry—the ‘‘gold standard’’ technique for detecting GM
demyelination—to evaluate demyelination in the cerebral
cortex, cerebellum, thalamus and spinal cord.
While several studies have compared the frequency of MS
plaques within different brain regions, few have included tissue
from the spinal cord.8 We observed a striking preponderance for
WM demyelination in the cord in comparison with the other
WM structures examined. The extent of GM demyelination is
also much greater in the spinal cord than in the cerebral cortex
and deep GM structures. However, in contrast with the
situation in the WM, the extent of GM demyelination in the
cerebellum is comparable to that in the cord. We note that
plaques which cause particularly disabling symptoms are likely
to be overrepresented in an autopsy series; such sites include the
brainstem and spinal cord. Therefore, while anatomical factors
may indeed predispose to plaques in these areas, this may be
exaggerated by sampling bias.
PGMd was greater than PWMd in all of the regions studied
(fig 4); these differences were significant in the motor cortex,
cerebellum and spinal cord. We cannot conclusively state that
demyelination is more extensive in the GM than in the WM as
several areas have not been sampled, notably the periventricular
tissue, brainstem and optic nerves. However, we have included
material from the spinal cord, subcortical WM, corpus callosum
(present on the cingulate sections) and the cerebellum, all of
which are considered predilection sites for WM plaques.1
Demyelination in the cerebral and cerebellar cortex
In keeping with previous studies, the majority of cerebral
cortical lesions were subpial in location.4 5 These often involved
extensive lengths of the cortical ribbon. Consistent with
Kutzelnigg et al, we found no correlation between PGMd and
PWMd in the cerebral cortex, suggesting that cortical demyelina-
tion, particularly subpial demyelination, occurs by an indepen-
dent mechanism to WM demyelination.5 Subpial lesions do not
appear to occur in a perivenous distribution; they frequently
cover extensive areas, extending from the surface of the brain
into the cerebral cortex.4 It has been suggested that subpial
demyelination is mediated by a ‘‘myelinotoxic factor’’, gener-
ated by inflammatory cells in the meninges or the CSF, diffusing
inward from the surface of the brain.4 9 Kutzelnigg et al found
subpial demyelination to be most pronounced within deep
invaginations of the cortex, including the cingulate, possibly
reflecting regional differences in CSF flow, with extensive
demyelination occurring in areas of CSF stasis.9
Consistent with a recent study, we have demonstrated that
the cerebellar cortex is a predilection site for demyelination,
with PGMd exceeding 70% in six of the 13 cases examined in the
current study.10 The cerebellum also showed the greatest
difference between PGMd (mean 43.7%) and PWMd (mean
8.7%). Like the subpial plaques of the cerebral cortex, subpial
cerebellar lesions are extensive, typically involving multiple
folia. PGMd in the cingulate correlates with PGMd in the
cerebellum, but not with PGMd in the spinal cord, further
suggesting that subpial demyelination occurs by a different
mechanism to demyelination at other sites.
Both subpial cerebellar lesions and the so-called type IV
plaques of the cerebral cortex involve the full thickness of the
cortex, without impinging on the subcortical WM.4 A propor-
tion of spinal cord plaques also show strict respect for the GM/
WM boundary, suggesting a common pathogenic mechanism.
We have previously suggested that this pattern of plaque
morphology may reflect a relative failure of remyelination in the
GM, giving rise to extensive areas of demyelinated GM with
apparent sparing of the adjacent WM.6 Alternatively, differences
in the extent of demyelination between WM and GM structures
may stem from antigenic differences between GM myelin and
WM myelin or differences in the handling of interstitial fluid
between WM and GM.
The hypothesis that demyelination is mediated by a
myelinotoxic factor in the interstitial fluid is an attractive
one. Interstitial fluid in GM drains preferentially along
perivascular (Virchow Robin) channels to the CSF, while
interstitial fluid in WM also spreads through the extracellular
spaces between nerve fibres; in the WM of the brain this fluid
predominantly drains into the ventricles.11 There is some
evidence that interstitial fluid is cleared more efficiently from
WM than GM.11 GM/WM differences in interstitial fluid
drainage may thereby result in areas of GM demyelination
with sparing of the adjacent WM. Furthermore, a myelinotoxic
substance originating in the interstitial fluid could potentially
circulate within the Virchow Robin space (resulting in
perivenular demyelination) and the CSF (mediating subpial
and periventricular demyelination).12 We acknowledge that the
majority of plaques in our postmortem series are likely to be
longstanding. Because of a paucity of actively demyelinating
lesions, we have not been able to adequately assess plaque
morphology in the early stages of lesion development.
Spinal cord and thalamic demyelination
We have previously examined GM demyelination in the spinal
cord in detail.6 In the current study, we have confirmed the
finding of substantial GM involvement throughout the cord.
We noted that despite our speculations that subpial demyelina-
tion is mediated by a factor related to the CSF, GM
demyelination is even more extensive in the spinal cord where
the GM is not bathed in CSF. Animal studies indicate marked
differences between the GM of the brain and spinal cord in
terms of their response to injury. Following injection of
proinflammatory cytokines, leucocyte infiltration and blood–
brain barrier breakdown is more pronounced in the spinal cord
GM in comparison with the striatum.13 14 Similar differences
between sites may result in regional differences in the extent of
GM demyelination.
Consistent with previous work, we detected a modest degree
of demyelination in the thalamus.7 The plaque borders within
the deep GM structures did not appear to respect the GM/WM
Figure 4 Proportion of grey matter (GM) that is demyelinated and the
proportion of white matter (WM) that is demyelinated at the different
sites of the CNS. Values represent mean (SE). Spinal cord values
represent the pooled results from the three cord levels.
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boundary. While the ependymal surface was not identifiable on
all of the sections, subependymal GM plaques were present in a
number of cases, sometimes extending over a relatively large
area (fig 3C). While the majority of periventricular WM plaques
demonstrate a perivenular distribution, a smaller number
appear to arise from the ependymal surface of the ventricle
itself, suggesting that inflammatory cells or a demyelinating
factor within the ventricular system may be responsible for the
formation of a proportion of plaques.15 Further work is required
to examine the relationship between periventricular GM
plaques and subependymal veins and to compare the extent of
periventricular demyelination between GM and WM structures.
Influence of disease duration and MS subtype
In agreement with previous work, we found no correlation
between disease duration and the extent of GM demyelina-
tion.5 6 However, disease duration was less than 10 years in only
one subject; the lesion counts observed therefore reflect years of
cumulative pathology. Studies on patients with shorter disease
durations are required to determine whether GM demyelination
is an early or late event or indeed whether it occurs consequent
to WM injury.
Kutzelnigg et al have suggested cortical demyelination may be
a pathological correlate of disease progression.5 Because of a
paucity of PPMS and RRMS cases, we have been unable to
investigate the influence of MS subtype on the extent of
demyelination. However, in the single RRMS case, 18.7% of the
cingulate was demyelinated, suggesting extensive cortical
demyelination is not exclusively a feature of progressive disease.
Interestingly no cortical plaques were detected in the two PPMS
cases, although we have examined relatively small areas of
cortex.
CONCLUSION
We demonstrated substantial variation in the extent of both
GM and WM demyelination between different regions of the
CNS. Of the areas examined, GM demyelination was most
extensive in the spinal cord and cerebellum, while WM
demyelination was most prominent in the spinal cord.
Demyelination was greater in the GM than in the WM at each
anatomical site. Further work is required to better characterise
these GM plaques—for example, examining inflammatory cell
infiltration, blood–brain barrier breakdown, gliosis and remye-
lination—in order to understand the factors that influence
lesion topography and the apparent preponderance for GM
demyelination.
Acknowledgements: Abhi Vora of the UK Multiple Sclerosis Brain Bank provided the
autopsy material.
Funding: The study was supported by funding from the Multiple Sclerosis Society of
Great Britain and Northern Ireland (grant No 801/03, NE).
Competing interests: None.
Ethics approval: The local research ethics committee approved the study.
REFERENCES
1. Lassmann H. Pathology of multiple sclerosis. In: Compston A, Ebers G, McDonald I,
et al, eds. McAlpines multiple sclerosis, 3rd Edn. London: Churchill Livingstone,
1998:323–58.
2. Fog T. Topographic distribution of plaques in the spinal cord in multiple sclerosis.
Arch Neurol Psychiatry 1950;63:382–414.
3. Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple
sclerosis. J Neurol Neurosurg Psychiatry 1962;25:315–20.
4. Bo L, Vedeler CA, Nyland HI, et al. Subpial demyelination in the cerebral cortex of
multiple sclerosis patients. J Neuropathol Exp Neurol 2003;62:723–32.
5. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse
white matter injury in multiple sclerosis. Brain Nov 2005;128:2705–12.
6. Gilmore CP, Bo L, Owens T, et al. Spinal cord gray matter demyelination in multiple
sclerosis—a novel pattern of residual plaque morphology. Brain Pathol 2006;16:202–8.
7. Vercellino M, Plano F, Votta B, et al. Grey matter pathology in multiple sclerosis.
J Neuropathol Exp Neurol 2005;64:1101–7.
8. Raine CS. The neuropathology of multiple sclerosis. In: Raine CS, McFarland HF,
Tourtellotte WM, eds. Multiple sclerosis. London: Chapman and Hall Medical,
1997:151–72.
9. Kutzelnigg A, Lassmann H. Cortical demyelination in multiple sclerosis: A substrate
for cognitive deficits? J Neurol Sci 15 2006;245:123–6.
10. Kutzelnigg A, Faber-Rod JC, Bauer J, et al. Widespread demyelination in the
cerebellar cortex in multiple sclerosis. Brain Pathol 2007;17:38–44.
11. Weller RO, Kida S, Zhang ET. Pathways of fluid drainage from the brain—
morphological aspects and immunological significance in rat and man. Brain Pathol
1992;2:277–84.
12. Gay FW. Early cellular events in multiple sclerosis. Intimations of an extrinsic
myelinolytic antigen. Clin Neurol Neurosurg 2006;108:234–40.
13. Schnell L, Fearn S, Klassen H, et al. Acute inflammatory responses to mechanical
lesions in the CNS: differences between brain and spinal cord. Eur J Neurosci
1999;11:3648–58.
14. Schnell L, Fearn S, Schwab ME, et al. Cytokine-induced acute inflammation in the
brain and spinal cord. J Neuropathol Exp Neurol 1999;58:245–54.
15. Adams CW, Abdulla YH, Torres EM, et al. Periventricular lesions in multiple sclerosis:
their perivenous origin and relationship to granular ependymitis. Neuropathol Appl
Neurobiol 1987;13:141–52.
Research paper
J Neurol Neurosurg Psychiatry 2009;80:182–187. doi:10.1136/jnnp.2008.148767 187
 group.bmj.com on August 16, 2011 - Published by jnnp.bmj.comDownloaded from 
doi: 10.1136/jnnp.2008.148767
online October 1, 2008
 2009 80: 182-187 originally publishedJ Neurol Neurosurg Psychiatry
 
C P Gilmore, I Donaldson, L Bö, et al.
 
matter nuclei and the spinal cord
greycerebral cortex, cerebellar cortex, deep 
sclerosis: a comparison between the
of grey matter demyelination in multiple 
Regional variations in the extent and pattern
 http://jnnp.bmj.com/content/80/2/182.full.html
Updated information and services can be found at: 
These include:
References
 http://jnnp.bmj.com/content/80/2/182.full.html#related-urls
Article cited in: 
 
 http://jnnp.bmj.com/content/80/2/182.full.html#ref-list-1
This article cites 11 articles, 2 of which can be accessed free at:
service
Email alerting
the box at the top right corner of the online article.
Receive free email alerts when new articles cite this article. Sign up in
Collections
Topic
 (1662 articles)Multiple sclerosis   
 (2141 articles)Brain stem / cerebellum   
 (45820 articles)Immunology (including allergy)   
 
Articles on similar topics can be found in the following collections
Notes
 http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
 http://journals.bmj.com/cgi/reprintform
To order reprints go to:
 http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
 group.bmj.com on August 16, 2011 - Published by jnnp.bmj.comDownloaded from 
